Natco Pharma Ltd. — Call Transcript 2026

May 30, 2026

NATCO

Natco Pharma Limited

Regd. Off.: NATCO HOUSE, Road No. 2, Banjara Hills, Hyderabad - 500034.

Telangana, INDIA. Tel: +91 40 23547532, Fax: +91 40 23548243

CIN: L24230TG1981PLC003201, www.natcopharma.co.in

May 30, 2026

Corporate Relationship Department
M/s. BSE Ltd.
Mumbai 400 001

Manager – Listing
M/s. National Stock Exchange of India Ltd
Mumbai 400 051

Scrip Code: 524816
Scrip Code: NATCOPHARM

Dear Sir

Sub:- Transcript of earnings conference call held on May 29, 2026
Ref:- Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015

We are enclosing herewith the copy of transcript of the Company's earnings conference call for Q4 FY25-26 held on May 29, 2026. The transcript is also available on the website of the company i.e., https://admin.natcopharma.co.in/wp-content/uploads/2025/08/Q4FY26.mp3

Thanking you

Yours faithfully

For NATCO Pharma Limited

VENKAT
Dyed the signed by
DORAY RAMISH
RAMISH
CHEKURI
DORAY RAMISH
DORAY
KAN CHEKURI
DORAY
KAN CHEKURI